No Detail Found!

Diagnostics pathology insights to pro-apoptotic potential of eugenol against human cervical cancer cell line

Author(s)
Aafia Afridi Departments of Pathology, Hamza Surgical Hospital, Peshawar, Pakistan
Maeesa Wadood Baqai Medical University, Karachi, Pakistan
Abdul Rehman Khalil Shaikh Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan
Abdul Mannan Jehangir Cancer Center, Nishtar Medical University and Hospital, Multan, Pakistan
Haseeb Khaliq Shaikh Zayd Hospital, Lahore, Pakistan
Madeeha Minhas College of Science and Health professions, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
Abstract
Objective: To explore the anti-cancer potential of eugenol (4-allyl-2-methoxyphenol) on HeLa (Henrietta Lacks) human cervical cancer cell line. Methodology: This In-vitro lab study worked on translating lab results into IC50 (half-maximal inhibitory concentration) values which depended on MTT assaybased outcomes [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide]. It is used for evaluating eugenol's concentrations focused effects on HeLa cell lines while performing gene expression studies through RT-qPCR (Quantitative Reverse Transcription Polymerase Chain Reaction) analysis of apoptotic mediator genes (Intrinsic Biomarkers Caspases). Results: Evaluation using IC50 revealed eugenol at 14.1 uM effectively induced pro-apoptotic biomarkers Caspase-3 and Caspase-9 in HeLa cells at relative gene expression levels of 12.9 and 12.3. Conclusion: Our data confirmed robust pro-apoptotic anti-cancer properties of eugenol against HeLa cell lines. Future investigations need to discover the main pathways through which eugenol fights cancer in HeLa cell lines.
Publication Details
Page(s) 374-376
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 50, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
HeLa, Eugenol, pro-apoptotic potential, anti-cancer activity.
References
Bray FF,Ferlay J,Soerjomataram I,Siegel RL,Torre LA,Jemal AJ .2020 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin, 70 : 313.
Arbyn M,Weiderpass E,Bruni L,de Sanjosé S,Saraiya M,Ferlay J .2020 .Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health, 8 : e191-203.
Swetha M,Keerthana CK,Rayginia TP,Anto RJ .2022 .Cancer chemoprevention: A strategic approach using phytochemicals. Front Pharmacol, 12 : 809308.
Damasceno RO,Pinheiro JL,Rodrigues LH,Gomes RC,Duarte AB,Emídio JJ .2024 .. Anti-Inflammatory and Antioxidant Activities of Eugenol: An Update. Pharmaceuticals, 17 : 1505-9.
Nisar MF,Khadim M,Rafiq M,Chen J,Yang Y,Wan CC .2021 .Pharmacological properties, and health benefits of eugenol: A comprehensive review. Oxid Med Cell Long, : 2497354.
Novohradsky V,Babu T,Kostrhunova H,Plaskow M,Markova L,Acharya S .2025 .Cisplatin-eugenol Pt (IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacy. Biomed Pharmacother, 183 : 117854.
Zuñiga Martinez MD,López Mendoza CM,Tenorio Salazar J,García Carrancá AM,Cerbón Cervantes MA,Alcántara-Quintana LE .2022 .Establishment, authenticity, and characterization of cervical cancer cell lines. Mol Cell Oncol, 9 : 2078628.
Padhy I,Paul P,Sharma T,Banerjee S,Mondal A .2022 .Molecular mechanisms of action of eugenol in cancer: recent trends and advancement. Life, 12 : 1795.
Kari S,Subramanian K,Altomonte IA,Murugesan A,YliHarja O,Kandhavelu M. .2022 .Programmed cell death detection methods: a systematic review and a categorical comparison. Apoptosis, 27 : 482-508.
Kashyap D,Garg VK,Goel N. .2021 .Intrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis. Adv Prot Chem Struct Biol, 125 : 73-120.
Begum SN,Ray AS,Rahaman CH .2022 .A comprehensive and systematic review on potential anticancer activities of eugenol: From pre-clinical evidence to molecular mechanisms of action. Phytomedicine, 107 : 154456-9.
Zari AT,Zari TA,Hakeem KR .2021 .Anticancer properties of eugenol: A review. Molecules, 26 : 7407-9.
Aburel OM,Pavel IZ,Dănilă MD,Lelcu T,Roi A,Lighezan R .2021 .Pleiotropic effects of eugenol: The good, the bad, and the unknown. Oxid Med Cell Longev, : 3165159.
Van Zogchel LM,Zappeij-Kannegieter L,Javadi A,Lugtigheid M,Gelineau NU,Lak NS .2021 .Specific and sensitive detection of neuroblastoma mRNA markers by multiplex RT-qPCR. Cancers, 13 : 150-4.
Tripathy NS,Sahoo L,Paikray SK,Dilnawaz F .2024 .Eugenol: The Phytocompound's Potential Biological Applications. Bio Nano Sci, 14 : 4044-55.
Novohradsky V,Babu T,Kostrhunova H,Plaskow M,Markova L,Acharya S .2025 .Cisplatin-eugenol Pt (IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacy. Biomed Pharmacother, 183 : 117854.
Arumugam K,Zochedh A,Chandran K,Sultan AB,Kathiresan T. Molecular,Simulation T. Molecular .2024 .Impact of Solvent‐Based Analysis of 2‐Methoxy‐4‐Allylphenol (Eugenol) Targeting Progesterone Receptor for Breast Cancer Therapy. Int J Quant Chem, 124 : e27506.
0

Citations

0

Downloads

72

Views